All Stories

  1. Sequence Artifacts in DNA from Formalin-Fixed Tissues: Causes and Strategies for Minimization
  2. DNA Ligase-Based Strategy for Quantifying Heterogeneous DNA Methylation without Sequencing
  3. Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors
  4. Methylation profiling of ductal carcinoma in situand its relationship to histopathological features
  5. Nuclear HIF1A expression is strongly prognostic in sporadic but not familial male breast cancer
  6. Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma
  7. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
  8. The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma
  9. Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment
  10. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines
  11. Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC
  12. A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma
  13. Reassessing Locus-Specific DNA Methylation in Head-and-Neck Squamous Cell Carcinoma (HNSCC) With Quantitative Methodology and Correlation With Patient Outcome
  14. Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome
  15. Candidate methylation profiling of ductal carcinoma in situ and its relationship to phenotype
  16. EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma
  17. Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
  18. The fusion partner specifies the oncogenic potential of NUP98 fusion proteins
  19. Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors
  20. Characterization of a Novel Tumorigenic Esophageal Adenocarcinoma Cell Line: OANC1
  21. Reducing Sequence Artifacts in Amplicon-Based Massively Parallel Sequencing of Formalin-Fixed Paraffin-Embedded DNA by Enzymatic Depletion of Uracil-Containing Templates
  22. PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer
  23. DNA methylation in ductal carcinoma in situof the breast
  24. Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2V617F mutant allele detection
  25. A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma
  26. No evidence for PALB2 methylation in high-grade serous ovarian cancer
  27. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer
  28. DNA methylation biomarkers in cancer: progress towards clinical implementation
  29. Abstract 2098: Reducing sequence artefacts from FFPE DNA for cancer diagnostics
  30. Abstract LB-377: Promoter methylation of the DAPK1 CLL predisposition gene is associated with chronic lymphocytic leukaemia risk
  31. No evidence for DNA methylation of theATMpromoter CpG island in chronic lymphocytic leukemia
  32. Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis
  33. Sensitive Quantification of Somatic Mutations Using Molecular Inversion Probes
  34. 1.31 Investigating Methylation of the Pro-Apoptotic CLL Tumour Suppressor Gene, Death Associated Protein Kinase 1 (DAPK1)
  35. 1.29 Development of Highly Accurate RT-qPCR Assays for Profiling the Expression of DNA Repair and Apoptosis Genes in CLL
  36. 1.30 Caspase 10 is Down-Regulated in Chronic Lymphocytic Leukemia
  37. Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer
  38. A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2genes
  39. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma
  40. Assessing combined methylation–sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation
  41. Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer
  42. Investigating the Potential Role of Genetic and Epigenetic Variation of DNA Methyltransferase Genes in Hyperplastic Polyposis Syndrome
  43. The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression
  44. Analysing DNA Methylation Using Bisulphite Pyrosequencing
  45. Closed-Tube PCR Methods for Locus-Specific DNA Methylation Analysis
  46. A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues
  47. Rarity ofAKT1andAKT3E17K mutations in squamous cell carcinoma of lung
  48. Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer
  49. Assessing Gene-Specific Methylation Using HRM-Based Analysis
  50. DNA methylation analysis of the HIF‐1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas
  51. No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer
  52. The implications of heterogeneous DNA methylation for the accurate quantification of methylation
  53. HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
  54. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast
  55. T1715 The Role of Genetic and Epigenetic Variation of DNA Methyltransferases in Hyperplastic Polyposis Syndrome
  56. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure
  57. A Multicenter Blinded Study to Evaluate KRAS Mutation Testing Methodologies in the Clinical Setting
  58. Detection of MGMT Promoter Methylation in Normal Individuals Is Strongly Associated with the T Allele of the rs16906252 MGMT Promoter Single Nucleotide Polymorphism
  59. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR
  60. Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B‐Raf
  61. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
  62. DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients
  63. Melting Curve Assays for DNA Methylation Analysis
  64. DNA methylation, epimutations and cancer predisposition
  65. Limited copy number - high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies
  66. Validation of a primer optimisation matrix to improve the performance of reverse transcription – quantitative real-time PCR assays
  67. No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer
  68. Methylation-sensitive high-resolution melting
  69. Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene
  70. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting
  71. Detection of NPM1 exon 12 mutations and FLT3 – internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia
  72. High resolution melting allows sensitive high-throughput assessment of methylation in tumour samples
  73. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies
  74. Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting
  75. Direct Genotyping of Single Nucleotide Polymorphisms in Methyl Metabolism Genes Using Probe-Free High-Resolution Melting Analysis
  76. Rapid detection of carriers with BRCA1 and BRCA2mutations using high resolution melting analysis
  77. Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection
  78. BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype
  79. Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail
  80. A new approach to primer design for the control of PCR bias in methylation studies
  81. Complete molecular response of e6a2 BCR-ABL-positive acute myeloid leukemia to imatinib then dasatinib
  82. High resolution melting for mutation scanning of TP53exons 5–8
  83. P3-002: High resolution melting analysis for rapid and sensitive EGFR mutation detection
  84. A Simple, Rapid, and Sensitive Method for the Detection of the JAK2 V617F Mutation
  85. Distinct Clinical and Pathological Features Are Associated with the BRAFT1799A(V600E) Mutation in Primary Melanoma
  86. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation
  87. Sensitive Detection of KIT D816V in Patients with Mastocytosis
  88. Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
  89. Methods for Analysis of DNA Methylation
  90. DNA repair gene inactivation in non-Hodgkin's lymphoma
  91. Screening for and analysis of methylation differences using methylation-sensitive single-strand conformation analysis
  92. Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer
  93. Clustering of 1p36 breakpoints distal to 1p36.2 in hematological malignancies
  94. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
  95. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
  96. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): A rapid method to screen for and analyze methylation
  97. Somatic mutations, acetylator status, and prognosis in colorectal cancer
  98. Characterization of a KRAB Family Zinc Finger Gene,ZNF195,Mapping to Chromosome Band 11p15.5
  99. A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles
  100. A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles
  101. 57. Detection of circulating tumour cells in patients with breast cancer using immunobead-PCR
  102. Localization of the human growth arrest-specific gene ( GAS1 ) to chromosome bands 9q21.3-q22, a region frequently deleted in myeloid malignancies
  103. Mapping of the chromosome 11 breakpoint of the t(4;11)(q21;p14–15) translocation
  104. A rapid and reliable PCR method for genotyping the ABO blood group
  105. A rare translocation (4;11)(q21;p14–15) in an acute lymphoblastic leukemia expressing T-cell and myeloid markers
  106. Review: Molecular analysis of the Philadelphia chromosome
  107. Detection of minimal residual tumour cells in stem cell harvests using molecular markers
  108. The significance of oncogene amplification in primary breast cancer
  109. DNA methylation and genetic inactivation at thymidine kinase locus: Two different mechanisms for silencing autosomal genes
  110. A frequent HindIII RFLP on chromosome 3p21–25 detected by a genomic erbA β sequence
  111. A Hin dIII RFLP for the HPRT pseudogene on chromosome 3 (HPRTP1)
  112. Gene mapping in marsupials and monotremes